Efficacy and Safety of Antiviral Agents in Preventing Allograft Rejection Following CMV Prophylaxis in High-Risk Kidney Transplantation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Many antiviral agents have been studied in clinical trials for allograft rejection prevention following cytomegalovirus (CMV) prophylaxis in high-risk kidney transplant patients. However, data on the most effective and safest treatment are lacking. We conducted a systematic review and network meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruenroengbun, Narisa, Sapankaew, Tunlanut, Chaiyakittisopon, Kamolpat, Phoompoung, Pakpoom, Ngamprasertchai, Thundon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010655/
https://www.ncbi.nlm.nih.gov/pubmed/35433502
http://dx.doi.org/10.3389/fcimb.2022.865735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010655/
https://www.ncbi.nlm.nih.gov/pubmed/35433502
http://dx.doi.org/10.3389/fcimb.2022.865735

Ejemplares similares